» Articles » PMID: 27071838

Microfluidic Cell Chips for High-throughput Drug Screening

Overview
Journal Bioanalysis
Specialty Chemistry
Date 2016 Apr 14
PMID 27071838
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

The current state of screening methods for drug discovery is still riddled with several inefficiencies. Although some widely used high-throughput screening platforms may enhance the drug screening process, their cost and oversimplification of cell-drug interactions pose a translational difficulty. Microfluidic cell-chips resolve many issues found in conventional HTS technology, providing benefits such as reduced sample quantity and integration of 3D cell culture physically more representative of the physiological/pathological microenvironment. In this review, we introduce the advantages of microfluidic devices in drug screening, and outline the critical factors which influence device design, highlighting recent innovations and advances in the field including a summary of commercialization efforts on microfluidic cell chips. Future perspectives of microfluidic cell devices are also provided based on considerations of present technological limitations and translational barriers.

Citing Articles

Recent Advances in Polymer Science and Fabrication Processes for Enhanced Microfluidic Applications: An Overview.

Alexandre-Franco M, Kouider R, Kassir Al-Karany R, Cuerda-Correa E, Al-Kassir A Micromachines (Basel). 2024; 15(9).

PMID: 39337797 PMC: 11433824. DOI: 10.3390/mi15091137.


Centrifugal Microfluidic Cell Culture Platform for Physiologically Relevant Virus Infection Studies: A Case Study with HSV-1 Infection of Periodontal Cells.

Christfort J, Ortis M, Nguyen H, Marsault R, Doglio A Biosensors (Basel). 2024; 14(8).

PMID: 39194630 PMC: 11352947. DOI: 10.3390/bios14080401.


Advances in Receptor-Mediated, Tumor-Targeted Drug Delivery.

Large D, Soucy J, Hebert J, Auguste D Adv Ther (Weinh). 2024; 2(1).

PMID: 38699509 PMC: 11064891. DOI: 10.1002/adtp.201800091.


Evaluating the antioxidant potential of resveratrol-gold nanoparticles in preventing oxidative stress in endothelium on a chip.

Fayazbakhsh F, Hataminia F, Mobaleghol Eslam H, Ajoudanian M, Kharrazi S, Sharifi K Sci Rep. 2023; 13(1):21344.

PMID: 38049439 PMC: 10696074. DOI: 10.1038/s41598-023-47291-6.


A comprehensive review on 3D tissue models: Biofabrication technologies and preclinical applications.

Xie R, Pal V, Yu Y, Lu X, Gao M, Liang S Biomaterials. 2023; 304:122408.

PMID: 38041911 PMC: 10843844. DOI: 10.1016/j.biomaterials.2023.122408.


References
1.
Ren K, Zhou J, Wu H . Materials for microfluidic chip fabrication. Acc Chem Res. 2013; 46(11):2396-406. DOI: 10.1021/ar300314s. View

2.
Ye N, Qin J, Shi W, Liu X, Lin B . Cell-based high content screening using an integrated microfluidic device. Lab Chip. 2007; 7(12):1696-704. DOI: 10.1039/b711513j. View

3.
Au A, Lee W, Folch A . Mail-order microfluidics: evaluation of stereolithography for the production of microfluidic devices. Lab Chip. 2014; 14(7):1294-301. PMC: 4362723. DOI: 10.1039/c3lc51360b. View

4.
Kim J, Taylor D, Agrawal N, Wang H, Kim H, Han A . A programmable microfluidic cell array for combinatorial drug screening. Lab Chip. 2012; 12(10):1813-22. PMC: 11656301. DOI: 10.1039/c2lc21202a. View

5.
Gates B, Xu Q, Stewart M, Ryan D, Willson C, Whitesides G . New approaches to nanofabrication: molding, printing, and other techniques. Chem Rev. 2005; 105(4):1171-96. DOI: 10.1021/cr030076o. View